Selecting Dlbcl Patients For Car T-Cell Therapies

Selecting DLBCL patients for CAR T-cell therapies

Selecting from CAR T-Cell Therapies in DLBCL

Choosing the right CAR-T therapy for R/R DLBCL

VJHemOnc – Video Journal of Hematology & HemOnc

CAR T-cell therapies: selecting patients & associated challenges

VJHemOnc – Video Journal of Hematology & HemOnc

Bispecifics & CAR-T therapy in DLBCL: sequencing and selecting between these agents

VJHemOnc – Video Journal of Hematology & HemOnc

Limitations of CAR T-cell therapy for DLBCL

VJHemOnc – Video Journal of Hematology & HemOnc

Selecting between autoSCT & CAR-T in DLBCL: patient selection, drug access, and long-term efficacy

VJHemOnc – Video Journal of Hematology & HemOnc

Selecting and risk stratifying patients with DLBCL for ASCT

VJHemOnc – Video Journal of Hematology & HemOnc

Dr Hu on Choosing Between Bispecific Antibodies vs CAR T-Cell Therapy in DLBCL

An overview of CAR-T therapy in DLBCL and MCL

VJHemOnc – Video Journal of Hematology & HemOnc

The value of CAR-T cell therapy in R/R DLBCL

VJHemOnc – Video Journal of Hematology & HemOnc

How do we select a patient with R/R DLBCL for CAR-T?

CAR T-Cell Therapy Offers Hope in DLBCL

Patient Selection for CAR-T Therapy in NHL

Dr. Karmali on the Impact of CAR T-Cell Therapy in DLBCL

Candidates for CAR T-Cell Therapy in DLBCL

Dr Maakaron on Choosing Between Bispecific Antibodies and CAR T-Cell Therapy in DLBCL

Patient selection for CAR-T in the UK

VJHemOnc – Video Journal of Hematology & HemOnc

Treating DLBCL with CAR-T: the best candidates and selecting a CAR-T product

VJHemOnc – Video Journal of Hematology & HemOnc

Management of relapsed DLBCL in era of CAR T therapy

International Academy for Clinical Hematology IACH